Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease in Europe through percutaneous cardiovascular interventions.
Our mission is to improve the quality of life of the population by reducing the impact of cardiac rhythm disturbances and reduce sudden cardiac death.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
NEW - Fundamental and Clinical Pharmacology - The journal is officially endorsed by the Working Group.As of October 2007 Fundamental and Clinical Pharmacology has become the new journal affiliated with the Working Group on Cardiovascular Pharmacology and Drug Therapy (WG). The journal is the official journal of the Société Française de Pharmacologie et de Thérapeutique and the Federation of the European Pharmacological Societies (EPHAR). It publishes reports describing important and novel developments in fundamental as well as clinical research relevant to drug therapy. The journal is indexed in major library databases, including Medline, and the current impact factor of 1.771 has been increasing the last three years.
Importantly, the journal will feature specific and readily visible publication space for the WG, identified by the WG Pharmacology logo, which is dedicated to editorials, guidelines, recommendations and consensus papers. Furthermore, these pages will feature announcements of symposia and other activities supported by the WG. The annual report of the WG will also be published in the journal. The Chairman of the WG Professor Faiez Zannad is one of two editors-in-chief for Fundamental and Clinical Pharmacology. It is the belief of the WG nucleus that this new collaboration will be an important tool to increase the visibility and enable broader communication of the activities of the WG.
Members of the Working Group are strongly encouraged to support this new collaboration and submit their work to the journal. As a further service to WG members, members of the Working Group on Cardiovascular Pharmacology and Drug Therapy will receive a 40 % discount in 2008 when subscribing to Fundamental and Clinical Pharmacology. To obtain the discount go to the Blackwell Publishing website and choose the rate for WG members according to your country of residence.
© 2017 European Society of Cardiology. All rights reserved